Clinical Trials for Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Find clinical trials for acute myeloid leukemia arising from previous myelodysplastic syndrome. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

NCT ID: NCT03128034

This clinical trial is looking at a new treatment called 211^astatine-BC8-B10 for patients with certain types of blood cancers, including high-risk acute myeloid leukemia (AML), acute lymphoblastic...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

NCT ID: NCT05554419

The ERASE Study is a clinical trial designed to explore different combinations of treatments for patients with persistent low-level Acute Myeloid Leukemia (AML) after their initial therapy. The tri...

Not yet recruiting

Phase: PHASE2 Type: interventional

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT ID: NCT03670966

This clinical trial is studying a new treatment approach for patients with high-risk acute leukemia or myelodysplastic syndrome, especially those whose disease has come back or is not responding to...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

NCT ID: NCT03630991

This clinical trial is studying two potential treatments, edetate calcium disodium and succimer, for patients with certain types of blood cancers, specifically acute myeloid leukemia (AML) or myelo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome

NCT ID: NCT03672539

This clinical trial is studying a combination of two treatments—liposome-encapsulated daunorubicin-cytarabine and gemtuzumab ozogamicin—for patients with relapsed or refractory acute myeloid leukem...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

NCT ID: NCT04269213

This clinical trial, called CPX-351, is looking at a new treatment option for patients under 60 years old who have secondary acute myeloid leukemia (AML). This type of leukemia can develop from oth...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States, Omaha, Nebraska, United States +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions